Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14360 | 774 | 49.4 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
563 | 3 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
382 | 2 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17086 |
14360 | 1 | GSTP1//UNIDAD DOCENTE BIOQUIM BIOL MOL//DNA METHYLATION | 774 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GSTP1 | authKW | 231195 | 6% | 12% | 48 |
2 | UNIDAD DOCENTE BIOQUIM BIOL MOL | address | 157800 | 1% | 100% | 4 |
3 | DNA METHYLATION | authKW | 136717 | 24% | 2% | 183 |
4 | HUMAN EPIGENOM | address | 129104 | 1% | 55% | 6 |
5 | BIOMED DEV TECHNOL DEV | address | 118350 | 0% | 100% | 3 |
6 | METHYLATION | authKW | 115137 | 18% | 2% | 137 |
7 | ONCOMETHYLOME SCI SA | address | 88761 | 0% | 75% | 3 |
8 | METHYLATED POLYMERASE CHAIN REACTION | authKW | 78900 | 0% | 100% | 2 |
9 | PROGRESSION BIOMARKERS | authKW | 78900 | 0% | 100% | 2 |
10 | RASSF1 GENE | authKW | 78900 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 10506 | 60% | 0% | 462 |
2 | Urology & Nephrology | 859 | 10% | 0% | 80 |
3 | Pathology | 408 | 7% | 0% | 55 |
4 | Genetics & Heredity | 337 | 10% | 0% | 77 |
5 | Medical Laboratory Technology | 171 | 3% | 0% | 21 |
6 | Medicine, Research & Experimental | 158 | 6% | 0% | 50 |
7 | Cell Biology | 96 | 8% | 0% | 60 |
8 | Biochemistry & Molecular Biology | 77 | 13% | 0% | 100 |
9 | Endocrinology & Metabolism | 69 | 5% | 0% | 38 |
10 | Biotechnology & Applied Microbiology | 18 | 4% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIDAD DOCENTE BIOQUIM BIOL MOL | 157800 | 1% | 100% | 4 |
2 | HUMAN EPIGENOM | 129104 | 1% | 55% | 6 |
3 | BIOMED DEV TECHNOL DEV | 118350 | 0% | 100% | 3 |
4 | ONCOMETHYLOME SCI SA | 88761 | 0% | 75% | 3 |
5 | PATHOL L ARMANNI | 52599 | 0% | 67% | 2 |
6 | ENGLANDER PRECIS MED | 45080 | 1% | 29% | 4 |
7 | PATHOL MOL IMMUNOL | 44460 | 2% | 7% | 16 |
8 | HEAD NECK CANC | 39634 | 2% | 5% | 19 |
9 | AHUS UNIV HOSP | 39450 | 0% | 100% | 1 |
10 | ANIM REPROD GERMPLASM ENHANCEMENT G | 39450 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL EPIGENETICS | 9697 | 1% | 2% | 10 |
2 | CLINICAL CANCER RESEARCH | 5341 | 6% | 0% | 45 |
3 | BREAST CANCER RESEARCH | 4627 | 2% | 1% | 16 |
4 | BREAST CANCER RESEARCH AND TREATMENT | 4238 | 4% | 0% | 28 |
5 | PROSTATE | 3801 | 3% | 0% | 21 |
6 | CIBA FOUNDATION SYMPOSIA | 3688 | 2% | 1% | 16 |
7 | EPIGENOMICS | 3062 | 1% | 1% | 6 |
8 | EPIGENETICS | 2458 | 1% | 2% | 4 |
9 | BMC CANCER | 2151 | 3% | 0% | 20 |
10 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2005 | 2% | 0% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GSTP1 | 231195 | 6% | 12% | 48 | Search GSTP1 | Search GSTP1 |
2 | DNA METHYLATION | 136717 | 24% | 2% | 183 | Search DNA+METHYLATION | Search DNA+METHYLATION |
3 | METHYLATION | 115137 | 18% | 2% | 137 | Search METHYLATION | Search METHYLATION |
4 | METHYLATED POLYMERASE CHAIN REACTION | 78900 | 0% | 100% | 2 | Search METHYLATED+POLYMERASE+CHAIN+REACTION | Search METHYLATED+POLYMERASE+CHAIN+REACTION |
5 | PROGRESSION BIOMARKERS | 78900 | 0% | 100% | 2 | Search PROGRESSION+BIOMARKERS | Search PROGRESSION+BIOMARKERS |
6 | RASSF1 GENE | 78900 | 0% | 100% | 2 | Search RASSF1+GENE | Search RASSF1+GENE |
7 | TWO COMPONENT EGFP REPORTER SYSTEM | 78900 | 0% | 100% | 2 | Search TWO+COMPONENT+EGFP+REPORTER+SYSTEM | Search TWO+COMPONENT+EGFP+REPORTER+SYSTEM |
8 | QM MSP | 71008 | 0% | 60% | 3 | Search QM+MSP | Search QM+MSP |
9 | HYPERMETHYLATION | 57998 | 4% | 5% | 31 | Search HYPERMETHYLATION | Search HYPERMETHYLATION |
10 | METHYLATION SPECIFIC PCR | 56690 | 2% | 8% | 17 | Search METHYLATION+SPECIFIC+PCR | Search METHYLATION+SPECIFIC+PCR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KRISTIANSEN, S , JORGENSEN, LM , GULDBERG, P , SOLETORMOS, G , (2013) ABERRANTLY METHYLATED DNA AS A BIOMARKER IN BREAST CANCER.INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. VOL. 28. ISSUE 2. P. 141-150 | 55 | 75% | 2 |
2 | STRAND, SH , ORNTOFT, TF , SORENSEN, KD , (2014) PROGNOSTIC DNA METHYLATION MARKERS FOR PROSTATE CANCER.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 15. ISSUE 9. P. 16544 -16576 | 54 | 50% | 25 |
3 | CHEN, Y , LI, J , YU, XX , LI, S , ZHANG, XR , MO, ZN , HU, YL , (2013) APC GENE HYPERMETHYLATION AND PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.EUROPEAN JOURNAL OF HUMAN GENETICS. VOL. 21. ISSUE 9. P. 929 -935 | 36 | 69% | 16 |
4 | FANG, C , WEI, XM , ZENG, XT , WANG, FB , WENG, H , LONG, XH , (2015) ABERRANT GSTP1 PROMOTER METHYLATION IS ASSOCIATED WITH INCREASED RISK AND ADVANCED STAGE OF BREAST CANCER: A META-ANALYSIS OF 19 CASE-CONTROL STUDIES.BMC CANCER. VOL. 15. ISSUE . P. - | 31 | 78% | 3 |
5 | CALLAHAN, CL , WANG, YJ , MARIAN, C , WENG, DY , ENG, KH , TAO, MH , AMBROSONE, CB , NIE, J , TREVISAN, M , SMIRAGLIA, D , ET AL (2016) DNA METHYLATION AND BREAST TUMOR CLINICOPATHOLOGICAL FEATURES: THE WESTERN NEW YORK EXPOSURES AND BREAST CANCER (WEB) STUDY.EPIGENETICS. VOL. 11. ISSUE 9. P. 643 -652 | 35 | 63% | 0 |
6 | PHE, V , CUSSENOT, O , ROUPRET, M , (2010) METHYLATED GENES AS POTENTIAL BIOMARKERS IN PROSTATE CANCER.BJU INTERNATIONAL. VOL. 105. ISSUE 10. P. 1364 -1370 | 32 | 68% | 39 |
7 | HE, KL , ZHANG, L , LONG, XH , (2016) QUANTITATIVE ASSESSMENT OF THE ASSOCIATION BETWEEN APC PROMOTER METHYLATION AND BREAST CANCER.ONCOTARGET. VOL. 7. ISSUE 25. P. 37920 -37930 | 28 | 67% | 0 |
8 | ZHOU, D , TANG, WW , WANG, WY , PAN, XY , AN, HX , ZHANG, Y , (2016) ASSOCIATION BETWEEN ABERRANT APC PROMOTER METHYLATION AND BREAST CANCER PATHOGENESIS: A META-ANALYSIS OF 35 OBSERVATIONAL STUDIES.PEERJ. VOL. 4. ISSUE . P. - | 28 | 67% | 0 |
9 | BLUTE, ML , DAMASCHKE, NA , JARRARD, DF , (2015) THE EPIGENETICS OF PROSTATE CANCER DIAGNOSIS AND PROGNOSIS: UPDATE ON CLINICAL APPLICATIONS.CURRENT OPINION IN UROLOGY. VOL. 25. ISSUE 1. P. 83 -88 | 27 | 64% | 5 |
10 | VAN NESTE, L , HERMAN, JG , OTTO, G , BIGLEY, JW , EPSTEIN, JI , VAN CRIEKINGE, W , (2012) THE EPIGENETIC PROMISE FOR PROSTATE CANCER DIAGNOSIS.PROSTATE. VOL. 72. ISSUE 11. P. 1248-1261 | 45 | 38% | 41 |
Classes with closest relation at Level 1 |